Every recall we track for Direct Rx — 37 in all — plus the complaints and injury reports the public filed about them.
Direct Rx recalls DULOXETINE D/R 30mg capsules (NDC 61919-482-30) and 60-capsule packs (NDC 61919-482-60) due to N-nitroso-duloxetine impurity exceeding FDA safety limits. Affected lots expire 04/30/2027.
Direct Rx recalls 30mg Duloxetine capsules due to nitrosamine impurity exceeding safety limits. Affected lots include specific NDC numbers and expiration dates. Consumers should stop using and consult a healthcare provider.
Direct Rx recalls 20mg Duloxetine 30-count bottles due to nitrosamine impurity exceeding safety limits. Consumers should check lot numbers and contact the manufacturer for details.
Direct Rx recalls 0.3% Ciprofloxacin Ophthalmic Solution bottles where the cap spike gets stuck in the nozzle, making it impossible to dispense the solution. Affected lots have specific expiration dates.
Direct Rx recalls 800mg ibuprofen tablets (Motrin) that failed stability testing for impurities. Products with NDC codes 61919-0621-15 to 61919-0621-72 are affected. No remedy specified in official notice.
Direct Rx is recalling 0.5 mg Alprazolam C-IV tablets due to potential cross contamination during repackaging. This recall affects specific lots and expiration dates. Consumers should check their product details.
Direct Rx is recalling Alprazolam C-IV 2mg tablets due to potential cross contamination during repackaging. This recall affects specific lots and expiration dates. Consumers should check their product details and contact the manufacturer for instructions.
Direct Rx is recalling Alprazolam C-IV 1mg tablets due to potential cross contamination during repackaging. Affected products include 30-tab and 60-tab bottles with specific NDC numbers and expiration dates.
Direct Rx recalls 20mg Simvastatin tablets due to cGMP deviations. Affected lots expire through 2025. Consumers should check NDC numbers and lot dates for affected products.
Direct Rx recalls 10mg Montelukast Sodium Tablets (Rx only) due to cGMP deviations. Affected products include 30-count and 90-count bottles with specific lot numbers and expiration dates. Consumers should contact the manufacturer for details.
Direct Rx recalls 5mg finasteride tablets with cGMP deviations. Affected lots expire 12/31/24. Consumers should check product details and contact manufacturer.
Direct Rx recalls 30-count and 90-count Simvastatin 10mg tablets due to cGMP deviations. Affected lots expire by 10/31/23 and 6/30/23. Consumers should check their bottle labels for NDC numbers.
Direct Rx recalls 30-count Ropinirole 1mg tablets due to cGMP deviations. Affected lots expired 8/31/23. Consumers should check NDC 72189-0364-30.
Direct Rx recalls 2mg Glimepiride tablets due to cGMP deviations. Affected lots expire 9/30/2023 to 4/30/2024. Check your bottle's NDC and lot number.
Direct Rx recalls 4mg Glimepiride tablets due to cGMP deviations. Affected lots expire by 3/31/2024. Consumers should check product details and contact manufacturer.
Direct Rx recalls 30-count Ropinirole 0.25mg tablets (NDC 72189-0364-30) due to cGMP deviations. Affected lots expire 7/31/23. No remedy provided in official notice.
Direct Rx Simvastatin 40mg tablets (90-count) with specific lot numbers recalled due to cGMP deviations. Consumers should check their bottles for listed lot numbers and contact the manufacturer for guidance.
Direct Rx recalls 5mg Simvastatin tablets due to cGMP deviations. Affected lots expire 6/30/23. Consumers should check product details and contact manufacturer.
Direct Rx recalls 1 mg Glimepiride tablets (NDC 61919-0723-30 and 61919-0723-90) due to cGMP deviations. Affected lots expire by 5/31/2024 and 1/31/2024. Consumers should check their bottles for lot numbers.
Direct Rx recalls 0.5% moxifloxacin eye drops due to stability concerns. Affected lots expire 4/30/23. Contact for return instructions.
Direct Rx recalls 0.1% Triamcinolone Acetonide cream tubes due to reported gritty texture and lack of effectiveness. Consumers should check product details and contact the manufacturer for guidance.
Direct Rx recalls 100mg Zonisamide capsules due to quality control gaps in microbiology testing. Affected lots from June 2023 expire June 30, 2023. No remedy specified in official notice.
Direct Rx recalls Losartan Pot/HCTZ 100/25 mg tablets (NDC 72189-289-90) due to AZIDO impurity levels above safety limits. Affected lots expire 1/31/25.
Direct Rx recalls Losartan Pot/HCTZ 50/12.5 mg tablets (NDC 72189-297-90) due to AZIDO impurities exceeding safety limits. Affected lots expire 1/31/25.
Direct Rx recalls Losartan Pot/HCTZ 100/12.5 mg 90-tab tablets (NDC 72189-290-90) due to AZIDO impurity levels exceeding safety limits. Affected lots manufactured by Macleods Pharma USA, Inc. in Plainsboro, NJ.
Direct Rx recalls Losartan/HCTZ 100/12.5mg tablets with AZIDO impurities above safe levels. Affected lots from 2021-2023. Stop using immediately.
Direct Rx recalls 60-count Alprazolam C-IV 2mg bottles (NDC 72189-0058-60) from lot 07NO1901 due to potential cross-contamination at the contract manufacturer. Consumers should check their prescription bottles.
Direct Rx recalls 60-count Alprazolam C-IV 1mg bottles due to potential cross-contamination at the contract manufacturer. Affected lots expire May 2022.
Direct Rx recalls 0.5% moxifloxacin eye drops due to failed impurities and degradation tests. Products with specific lot numbers and expiration dates are affected. Consumers should check their packaging for details.
Direct Rx recalls 150mL Diclofenac Sodium Topical Solution 1.5% due to leaking containers. This could lead to medication exposure risks.
Direct Rx recalls 30-count Zonisamide 100mg capsules due to quality control gaps in microbiology testing. Affected lots from May 2023 expire May 31, 2023. Stop using immediately.
